Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hemonc.2017.05.009 http://scihub22266oqcxt.onion/10.1016/j.hemonc.2017.05.009 C5925745!5925745!28641097     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hematol+Oncol+Stem+Cell+Ther 2017 ; 10 (4): 220-7 Nephropedia Template TP {{tp|p=28641097|t=2017. Long Term Complications After Hematopoietic Cell Transplantation |pdf=|usr=}}{{28641097}} gab.com Text Long Term Complications After Hematopoietic Cell Transplantation JO: Hematol Oncol Stem Cell Ther http://www.kidney.de/pget.php?&tw=1&pmid=28641097 #FOAvip The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease remains in remission for the first 2-5 years after transplantation, it is estimated approximately 80-90% will be alive over the subsequent 10-years. However, their relative mortality rates continue to remain higher than their general population peers with late complications contributing to significant long-term morbidity and mortality. Late effects in HCT survivors include secondary cancers, organ specific complications, late infections, quality of life impairments, psychosocial issues, sexual and fertility concerns, financial toxicity and issues around return to work/school. A patient-centric and multidisciplinary approach to HCT survivorship care with collaborative and coordinated care from transplant centers and community healthcare providers is necessary to ensure their long-term health. Lifelong followup of HCT survivors is recommended, with established guidelines serving as the template for providing screening and preventive care based on patient-specific exposures. This review discussed common late complications, models for care delivery, and gaps and priorities for future research in the field of HCT survivorship. Twit Text FOAVip Long Term Complications After Hematopoietic Cell Transplantation ????Hematol Oncol Stem Cell Ther http://www.kidney.de/pget.php?&tw=1&pmid=28641097 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28641097 #FOAvip English Wikipedia <ref>{{Cite pmid|28641097}}</ref> Long Term Complications After Hematopoietic Cell Transplantation #MMPMID28641097 Majhail NS Hematol Oncol Stem Cell Ther 2017[Dec]; 10 (4): 220-7 PMID28641097show ga The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease remains in remission for the first 2-5 years after transplantation, it is estimated approximately 80-90% will be alive over the subsequent 10-years. However, their relative mortality rates continue to remain higher than their general population peers with late complications contributing to significant long-term morbidity and mortality. Late effects in HCT survivors include secondary cancers, organ specific complications, late infections, quality of life impairments, psychosocial issues, sexual and fertility concerns, financial toxicity and issues around return to work/school. A patient-centric and multidisciplinary approach to HCT survivorship care with collaborative and coordinated care from transplant centers and community healthcare providers is necessary to ensure their long-term health. Lifelong followup of HCT survivors is recommended, with established guidelines serving as the template for providing screening and preventive care based on patient-specific exposures. This review discussed common late complications, models for care delivery, and gaps and priorities for future research in the field of HCT survivorship. äLong Term Complications After Hematopoietic Cell Transplantation (epmc).pdf DeepDyve Pubget Overpricing